VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
This Quarter Return
+3.66%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$1.21B
AUM Growth
+$1.21B
(+20%)
Cap. Flow
+$170M
Cap. Flow
% of AUM
14.11%
Top 10 Holdings %
Top 10 Hldgs %
14.79%
Holding
464
New
45
Increased
341
Reduced
52
Closed
26
Top Buys
| 1 |
Zebra Technologies
ZBRA
|
$8.74M |
| 2 |
PTC
PTC
|
$7.55M |
| 3 |
Oceaneering
OII
|
$7M |
| 4 |
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
|
$6.18M |
| 5 |
Manhattan Associates
MANH
|
$6.07M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$16.8M |
| 2 |
Xerox
XRX
|
$7.86M |
| 3 |
Elbit Systems
ESLT
|
$4.36M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
$4.01M |
| 5 |
Bank of America
BAC
|
$2.86M |
Sector Composition
| 1 | Technology | 21.24% |
| 2 | Industrials | 12.89% |
| 3 | Healthcare | 11.15% |
| 4 | Financials | 9.91% |
| 5 | Consumer Discretionary | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
276
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.48M | 0.12% |
49,477
+2,101
| +4% | +$62.8K |
|
|
CATM
277
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $1.48M | 0.12% |
44,876
+784
| +2% | +$25.8K |
|
|
ATW
278
DELISTED
Atwood Oceanics
ATW
| $1.47M | 0.12% |
180,722
+3,114
| +2% | +$25.4K |
|
|
XHR
279
Xenia Hotels & Resorts
XHR
$1.35B
| $1.47M | 0.12% |
75,734
+2,275
| +3% | +$44.1K |
|
280
Syndax Pharmaceuticals
SNDX
$1.41B
| $1.45M | 0.12% |
+103,558
| New | +$1.45M |
|
281
Urban Outfitters
URBN
$6.02B
| $1.43M | 0.12% |
76,966
+1,232
| +2% | +$22.8K |
|
282
Amazon
AMZN
$2.44T
| $1.41M | 0.12% |
1,454
-403
| -22% | -$390K |
|
283
Dynavax Technologies
DVAX
$1.19B
| $1.41M | 0.12% |
+145,705
| New | +$1.41M |
|
284
Charter Communications
CHTR
$36.3B
| $1.39M | 0.11% |
4,118
-601
| -13% | -$202K |
|
285
Innospec
IOSP
$2.18B
| $1.38M | 0.11% |
21,083
+254
| +1% | +$16.7K |
|
286
ImmunityBio
IBRX
$2.21B
| $1.38M | 0.11% |
181,152
+42,461
| +31% | +$322K |
|
287
Iovance Biotherapeutics
IOVA
$807M
| $1.36M | 0.11% |
185,628
+60,092
| +48% | +$442K |
|
288
Amgen
AMGN
$155B
| $1.34M | 0.11% |
7,756
+935
| +14% | +$161K |
|
|
KITE
289
DELISTED
Kite Pharma, Inc.
KITE
| $1.33M | 0.11% |
12,813
-5,147
| -29% | -$533K |
|
290
Merck
MRK
$210B
| $1.3M | 0.11% |
20,324
+3,622
| +22% | +$232K |
|
291
CytomX Therapeutics
CTMX
$336M
| $1.29M | 0.11% |
83,392
+7,468
| +10% | +$116K |
|
|
CLLS
292
Cellectis
CLLS
$258M
| $1.29M | 0.11% |
49,981
-1,013
| -2% | -$26.2K |
|
|
AGEN
293
Agenus
AGEN
$133M
| $1.28M | 0.11% |
327,706
+125,256
| +62% | +$490K |
|
|
ONC
294
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.28M | 0.11% |
28,458
-1,288
| -4% | -$58K |
|
|
RDC
295
DELISTED
Rowan Companies Plc
RDC
| $1.28M | 0.11% |
124,932
+2,130
| +2% | +$21.8K |
|
296
Alaunos Therapeutics
TCRT
$4.21M
| $1.27M | 0.11% |
204,744
+66,768
| +48% | +$415K |
|
297
Incyte
INCY
$16.5B
| $1.27M | 0.11% |
8,568
+839
| +11% | +$125K |
|
298
Atara Biotherapeutics
ATRA
$84.6M
| $1.27M | 0.11% |
90,598
+34,933
| +63% | +$489K |
|
|
BLCM
299
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.24M | 0.1% |
106,324
+49,739
| +88% | +$581K |
|
|
KDNY
300
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.22M | 0.1% |
107,057
+28,011
| +35% | +$319K |
|